Proteome Sciences (UK) Profile

GBp 0.04  1.29%

Proteome Sciences Summary

Proteome Sciences plc (PRM) is traded on London Stock Exchange in UK. It is located in Hamilton House and employs 36 people. The company currently falls under 'Nano-Cap' category with current market capitalization of 9.15 M. Proteome Sciences plc classifies itself under Healthcare sector and is part of Medical Laboratories and Research industry. This company has 295.18 M outstanding shares. PROTEOME SCIENCES has accumulated about 869 K in cash with (2.73 M) of positive cash flow from operations.
Check Proteome Sciences Probability Of Bankruptcy

Proteome Sciences plc Risk Profiles

Key Fundamentals

Proteome Sciences Against Markets

Current Ratings

Proteome Sciences 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 95% 
Equity ratings for Proteome Sciences plc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers. The company was incorporated in 1993 and is headquartered in London, the United Kingdom. Proteome Sciences operates under Medical Laboratories Research classification in UK and traded on London Stock Exchange exchange. It employs 36 people. more
NameProteome Sciences plc
CEO, DirectorJeremy HaighView All
Thematic ClassificationDrugsView All
Macroaxis Advice
Healthcare, Pharmaceuticals And Biosciences
InstrumentUK Stock View All
Business AddressHamilton House
ExchangeLondon Stock Exchange
IndustryMedical Laboratories and Research
Contact Number44 20 7043 2116

Diversify with Proteome Sciences plc

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Proteome Sciences plc to your portfolio


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


Proteome Sciences Corporate Directors
William Dawson Non-Executive Director
Roger McDowell Non-Executive Director
Christopher Pearce Chief Executive, Executive Director